Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED20/20 Biolabs Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2025 | Q3 2025 | N/A | -$0.17 | N/A | N/A | $417.98 K |
| 12/31/2024 | Q4 2024 | N/A | -$0.26 | N/A | N/A | $536.08 K |
| 09/29/2024 | Q3 2024 | N/A | -$0.39 | N/A | N/A | $361.01 K |
| 06/29/2023 | Q2 2023 | N/A | -$0.36 | N/A | N/A | $335.94 K |
| 03/30/2023 | Q1 2023 | N/A | -$0.42 | N/A | N/A | $419.38 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
20/20 Biolabs Inc Earnings: FAQ's
The conference call for 20/20 Biolabs Inc's latest earnings report can be listened to online.
The conference call transcript for 20/20 Biolabs Inc's latest earnings report can be read online.
20/20 Biolabs Inc (:AIDX) has a recorded annual revenue of $2.05 B.
20/20 Biolabs Inc (:AIDX) has a recorded net income of $-3,738,821,000.20/20 Biolabs Inc has generated $0 earnings per share over the last four quarters.
20/20 Biolabs Inc (:AIDX) has a price-to-earnings ratio of -3.25 and price/earnings-to-growth ratio is -0.03.